Director Christopher Gibson receives options and RSUs at Pacific Biosciences (PACB)
Rhea-AI Filing Summary
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. director Christopher Gibson reported equity awards consisting of stock options and restricted stock units tied to his recent Board appointment. He received stock options covering 77,842 shares of Common Stock at an exercise price of $1.52 per share, expiring on April 8, 2036. One-third of these option shares will vest on March 3, 2027, with the remainder vesting in equal monthly installments over the following 24 months, contingent on continued Board service. He also acquired 57,473 shares of Common Stock represented by restricted stock units that vest in three equal annual installments on March 3 of 2027, 2028, and 2029, subject to his continued service as a director. Following these grants, he directly holds 111,386 shares of Common Stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 57,473 shares
Net Buy
2 txns
Insider
Gibson Christopher
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 77,842 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 57,473 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 77,842 shares (Direct);
Common Stock — 111,386 shares (Direct)
Footnotes (2)
- F1. Mr. Gibson was elected to the Board of Directors on March 3, 2026. Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on March 3rd of each of 2027, 2028, and 2029, provided such Reporting Person continues to serve as a director through the applicable vesting dates.
- F2. One-third of the shares subject to the option will vest on March 3, 2027, which is the one year anniversary of Mr. Gibson joining the Board, and the remainder will vest in equal monthly installments thereafter for 24 months on the same date of the month as his initial start date, provided he continues to serve as a director through each vesting date.
Key Figures
Stock options granted: 77,842 shares
Option exercise price: $1.52 per share
Option expiration: April 8, 2036
+4 more
7 metrics
Stock options granted
77,842 shares
Stock Option grant on April 8, 2026
Option exercise price
$1.52 per share
Exercise price for 77,842 options
Option expiration
April 8, 2036
Expiration date of granted options
RSU shares granted
57,473 shares
Common Stock represented by RSUs granted April 8, 2026
Common shares after grants
111,386 shares
Total direct Common Stock holdings following transactions
Initial option vesting date
March 3, 2027
One-third of option shares vest on this date
RSU vesting period
2027-2029
Annual RSU vesting on March 3 of each year
Key Terms
Restricted Stock Unit ("RSU"), Stock Option (right to buy), vest in equal annual installments, Board of Directors, +1 more
5 terms
Restricted Stock Unit ("RSU") financial
"Each share is represented by a Restricted Stock Unit ("RSU")."
Stock Option (right to buy) financial
"security_title": "Stock Option (right to buy)""
vest in equal annual installments financial
"The RSUs will vest in equal annual installments on March 3rd"
Board of Directors financial
"Mr. Gibson was elected to the Board of Directors on March 3, 2026."
The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.
exercise price financial
"conversion_or_exercise_price": "1.5200""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did Christopher Gibson acquire in this PACB Form 4 filing?
Christopher Gibson received stock options and restricted stock units (RSUs). He was granted options for 77,842 shares at a $1.52 exercise price and 57,473 RSU shares, all tied to his role on Pacific Biosciences’ Board and subject to future vesting conditions.
How many PACB stock options were granted to director Christopher Gibson?
Christopher Gibson was granted options on 77,842 PACB shares. These options have a $1.52 per share exercise price and expire on April 8, 2036. Vesting begins March 3, 2027, with one-third vesting then and the rest monthly over the next 24 months.
What are the vesting terms of Christopher Gibson’s PACB restricted stock units?
The 57,473 RSU shares vest in three equal annual installments. They vest on March 3 of 2027, 2028, and 2029, provided Gibson continues to serve as a director through each applicable vesting date, aligning his compensation with ongoing Board service.
What is Christopher Gibson’s PACB common stock holding after these grants?
After the reported transactions, Gibson directly holds 111,386 PACB common shares. This total reflects the addition of 57,473 granted shares represented by RSUs, which will vest over time, in addition to his prior holdings as disclosed in the filing.
When do Christopher Gibson’s newly granted PACB stock options vest?
Gibson’s PACB options start vesting on March 3, 2027. One-third of the 77,842 option shares vest then, marking his one-year Board anniversary. The remaining two-thirds vest in equal monthly installments over the following 24 months, contingent on continued Board service.
Why were these PACB equity awards granted to Christopher Gibson?
The equity awards relate to Gibson’s election to the Board of Directors. He joined the Board on March 3, 2026, and received options and RSUs that vest over several years, designed to align his compensation with long-term service and company performance.